Crinetics Pharmaceuticals stock edges higher above $35 as momentum stays weak

Traders Union
All News
Companies
Crinetics Pharmaceuticals rises 1.87% today

Highlights

CRNX is consolidating near short-term support, with price action neutral to bearish and longer-term trends remaining negative.
Momentum signals are mixed, indicating a weak directional bias as the stock holds gains from a recent bounce.
The expected price range is $33.90 to $36.85 for the coming week, with significant upside moves unlikely and key resistance above $37.50.

Neutral to bearish bias as price faces clustered resistance

CRNX is trading at $35.12, just above the MA-20 ($35.01) but below the MA-50 ($37.46) and MA-200 ($41.65), reflecting near-term neutral to bearish pressure while longer-term trends remain negative. The Ichimoku Kijun sits at $37.96, above the current price and acting as immediate resistance. Near-term support is found at the MA-20 ($35.01), with key support at the MA-200 ($34.61, W1). Immediate resistance is at the Ichimoku Kijun ($37.96), with key resistance from the MA-50 ($37.46).

Mixed momentum as buying interest emerges after consolidation

Momentum signals are mixed, with D1 MACD giving a strong sell and ADX showing a weak trend (12.02). D1 RSI is neutral at 45.49, but Stoch RSI is overbought (95.14), while CCI is neutral. BBP (0.49, labeled oversold) suggests neither buyers nor sellers are clearly dominating intraday action. The Awesome Oscillator is neutral. In today's session, the price is up 1.87%, indicating a pickup in buying interest. Over the past week, CRNX has risen $0.65 (1.94%) from the previous weekly close of $34.47, holding near the upper part of the weekly range as weekly volatility stands at 9.72%. The price is consolidating after a recovery from its recent low.

Downward risk prevails as upside break seen unlikely

For the coming week, the expected price range is $33.90 to $36.85, keeping the price well above the 52-week low ($25.83) but far below the year’s high ($57.99). The calculated probability of a significant upside move is very low (less than 20%), making a downward move more likely. The baseline scenario sees CRNX fluctuating within a $33.90–$36.85 corridor amid weak directional momentum. A bullish scenario would require a break above $37.50 resistance, while a bearish scenario involves a fall below $34.60 support, possibly retesting lower weekly ranges.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that Crinetics Pharmaceuticals was exhibiting persistent bearish momentum, with technical indicators signaling ongoing downside risk. As market conditions evolve, traders should monitor for a decisive shift in volume or sentiment that could signal the emergence of a new trend.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.